Biology subjects

Allen, K. D.

Publications and source records attributed to Allen, K. D..

10 recordsLinked to original sources

bioRxiv2025

PKMζ-PKC{iota}/{lambda} double-knockout reveals the atypical PKCs are crucial for hippocampal late-LTP and spatial long-term memory

PKM{zeta}, a persistently active atypical PKC (aPKC) isoform, is thought to maintain late-phase long-term potentiation (late-LTP) and long-term memory. However, PKM{zeta}-knockout mice still exhibit hippocampal LTP and spatial memory while lacking neocortical LTP, questioning whether this kinase is fundamental to enduring synaptic potentiation and memory. Tsokas et al. (2016) showed the other aPKC, PKC{iota}/{lambda}, likely compensates for PKM{zeta} during maintenance in the hippocampus of PKM{zeta}-null mice. In wild-type mice, PKC{iota}/{lambda} drives early-LTP and short-term memory, while PKM{zeta} compensates for PKC{iota}/{lambda} knockout by supporting both early- and late-phase processes. Here we show PKC{iota}/{lambda} persistently increases during maintenance in two mouse models: PKM{zeta}-conditional knockout (cKO) mice, and double-knockout mice carrying both conditional deletion of PKC{iota}/{lambda} and constitutive loss of PKM{zeta}. In the double-knockout mice, PKC{iota}/{lambda} was measured while the kinase was still present, prior to its inducible ablation, to characterize its compensatory upregulation in late-LTP before removal. To test whether this compensation was functional, we ablated PKC{iota}/{lambda} in the hippocampus of the double-knockout mice. The double-knockout eliminated late-LTP, whereas individual knockout of either aPKC alone showed normal-appearing LTP. Double-knockout also abolished spatial long-term memory without affecting short-term memory. Thus, when PKM{zeta} is absent, PKC{iota}/{lambda} persists to maintain hippocampal late-LTP and long-term memory.

neuroscience↗

bioRxiv2024

A Novel Early Onset Spinocerebellar Ataxia 13 BAC Mouse Model with Cerebellar Hypoplasia, Tremor, and Ataxic Gait

Spinocerebellar ataxia 13 (SCA13) is an autosomal dominant neurological disorder caused by mutations in KCNC3. Our previous studies revealed that KCNC3 mutation R423H results in an early-onset form of SCA13. Previous biological models of SCA13 include zebrafish and Drosophila but no mammalian systems. More recently, mouse models with KCNC3 mutations presented behavioral abnormalities but without obvious pathological changes in the cerebellum, a hallmark of patients with SCA13. Here, we present a novel transgenic mouse model by bacterial artificial chromosome (BAC) recombineering to express the full-length mouse Kcnc3 expressing the R424H mutation. This BAC-R424H mice exhibited behavioral and pathological changes mimicking the clinical phenotype of the disease. The BAC-R424H mice (homologous to R423H in human) developed early onset clinical symptoms with aberrant gait, tremor, and cerebellar hypoplasia/atrophy. Histopathological analysis of the cerebellum in BAC-R424H mice showed progressive Purkinje cell loss and thinning of the molecular cell layer. Additionally, Purkinje cells of BAC-R424H mice showed significantly lower spontaneous firing frequency with a corresponding increase in inter-spike interval compared to that of wild-type mice. Our SCA13 transgenic mice recapitulate both neuropathological and behavioral changes manifested in human SCA13 R423H patients and provide an advantageous approach to understanding the role of voltage-gated potassium channel in cerebellar morphogenesis and function. This mammalian in vivo model will lead to further understanding of the R423H allelic form of SCA13 from the molecular to the behavioral level and serve as a platform for testing potential therapeutic compounds.

neuroscience↗

bioRxiv2024

Association of cerebellar inflammation and neurodegeneration in a novel spinocerebellar ataxia type 13 mouse model

BackgroundNeuroinflammation is a recognized pathological characteristic of neurodegenerative diseases. Spinocerebellar ataxia 13 (SCA13) is a progressive neurodegenerative disease with no effective treatments. Our previous studies reported human mutations in KCNC3 gene are causative for SCA13. Human R423H allelic mutation induces early-onset neurodegeneration and aberrant intracellular retention of Epidermal Growth Factor Receptor (EGFR) in drosophila. However, the neurodegeneration and inflammatory response induced by the R424H allele are unknown in a mammalian model of disease. MethodIn this study, a single Kcnc3 R424H mutation (Analogous to the human SCA13 R423H isoform) transgenic mice were created using CRISPR/Cas 9 technique. Motor function (gait, tremor, coordination and balance) and cerebellar volume (scanned and imaged with 7T MRI) of the R424H transgenic mice were evaluated at multiple timepoints. Neurodegeneration (Purkinje cells loss) as well as cerebellar (astroglia, microglia and macrophage activation) and peripheral (plasma cytokines levels) inflammatory responses were examined and analyzed. ResultThe R424H transgenic mice showed marked neurological motor dysfunction with high-frequency tremor, aberrant gait, and short latency to fall in Rotarod testing at 3 and 6 months of age. Abnormal spontaneous firing was recorded in electrophysiology of Purkinje cells. Pathological changes in our R424H transgenic mice included progressive Purkinje cell degeneration and cerebellar atrophy. Over-active microglia, astrocytes, and macrophages were observed in the cerebella of transgenic mice. Pearson correlation analyses indicated that the number of Calbindin positive cells, a Purkinje cell marker, showed a strong inverse correlation with the positive cell number of EGFR, phosphorylated EGFR (pEGFR), and CD68. The expression of EGFR/pEGFR was positively correlated with CD68 and Glial Fibrillary Acidic Protein. ConclusionTransgenic R424H mice provide a novel SCA13 model showing significant motor deficits, Purkinje cells loss, cerebellar inflammation, and atrophy. Our study suggests that the activation of inflammatory immune cells (astroglia, microglia and macrophages) and strong expression of EGFR/ pEGFR signal in these immune cells are associated with Purkinje cell loss in the cerebellum. This abnormal neuroinflammation may play a significant role in the aggressive procession of neurodegeneration.

neuroscience↗

bioRxiv2024

Structural dynamics of the methyl-coenzyme M reductase active site are influenced by coenzyme F430 modifications

Methyl-coenzyme M reductase (MCR) is a central player in methane biogeochemistry, governing methanogenesis and the anaerobic oxidation of methane (AOM) in methanogens and anaerobic methanotrophs (ANME), respectively. The prosthetic group of MCR is coenzyme F430, a nickel-containing tetrapyrrole derivative. Additionally, a few modified versions of F430 have been discovered, including the 172-methylthio-F430 (mt-F430) that functions with ANME-1 MCR. This study employs molecular dynamics (MD) simulations to unravel the intricacies of the active-site dynamics of MCR from Methanosarcina acetivorans and ANME-1 when bound to the canonical F430 compared to 172-thioether coenzyme F430 variants and substrates for methane formation. Overall, our simulations indicate that each MCR active site is optimized for a given version of F430 and support the importance of the Gln to Val substitution in accommodating the 172 methylthio modification. Notably, modifications in the 172 position disrupt the canonical coordination among cofactors in M. acetivorans MCR, implicating structural perturbations, but evidence of active site reorganization to maintain substrate positions suggest that the modified F430s could be accommodated in a methanogenic MCR. We additionally report the first quantitative estimate of MCR intrinsic electric fields pivotal in driving methane formation. Our results suggest that the electric field aligned along the CH3-S-CoM thioether bond facilitates homolytic bond cleavage, coinciding with the proposed catalytic mechanism. Structural perturbations, however, weaken and misalign these electric fields, emphasizing the significance of the active site structure in maintaining their integrity. In conclusion, our results deepen the understanding of MCR active-site dynamics, the enzymes organizational role in intrinsic electric fields for catalysis, and the interplay between active site structure and electrostatics. This work not only advances our comprehension of MCR functionality but also provides a foundation for future investigations employing sophisticated models to capture the complex electronic properties of MCR active sites quantitatively.

biophysics↗

bioRxiv2023

Control of Biofilm Formation by an Agrobacterium tumefaciens Pterin-Binding Periplasmic Protein Conserved Among Pathogenic Bacteria

Biofilm formation and surface attachment in multiple Alphaproteobacteria is driven by unipolar polysaccharide (UPP) adhesins. The pathogen Agrobacterium tumefaciens produces a UPP adhesin, which is regulated by the intracellular second messenger cyclic diguanylate monophosphate (cdGMP). Prior studies revealed that DcpA, a diguanylate cyclase-phosphodiesterase (DGC-PDE), is crucial in control of UPP production and surface attachment. DcpA is regulated by PruR, a protein with distant similarity to enzymatic domains known to coordinate the molybdopterin cofactor (MoCo). Pterins are bicyclic nitrogen-rich compounds, several of which are formed via a non-essential branch of the folate biosynthesis pathway, distinct from MoCo. The pterin-binding protein PruR controls DcpA activity, fostering cdGMP breakdown and dampening its synthesis. Pterins are excreted and we report here that PruR associates with these metabolites in the periplasm, promoting interaction with the DcpA periplasmic domain. The pteridine reductase PruA, which reduces specific dihydro-pterin molecules to their tetrahydro forms, imparts control over DcpA activity through PruR. Tetrahydromonapterin preferentially associates with PruR relative to other related pterins, and the PruR-DcpA interaction is decreased in a pruA mutant. PruR and DcpA are encoded in an operon that is conserved amongst multiple Proteobacteria including mammalian pathogens. Crystal structures reveal that PruR and several orthologs adopt a conserved fold, with a pterin-specific binding cleft that coordinates the bicyclic pterin ring. These findings define a new pterin-responsive regulatory mechanism that controls biofilm formation and related cdGMP-dependent phenotypes in A. tumefaciens and is found in multiple additional bacterial pathogens. SIGNIFICANCEBiofilms are bacterial communities attached to surfaces, physiologically distinct from free-living cells, and a common cause of persistent infections. Here we define the mechanism of a novel biofilm regulatory system based on excreted metabolites called pterins, that is conserved within a wide range of Gram-negative bacteria, including multiple pathogens of animals and plants. The molecular mechanism of pterin-dependent regulation is reported including structural determination of several members of a new family of pterin-binding proteins. Pterins are produced across all domains of life and mechanistic insights into this regulatory circuit could lead to new advances in antibiofilm treatments.

microbiology↗

bioRxiv2023

Technical Note: DeepLabCut-Display: open-source desktop application for visualizing and analyzing two-dimensional gait parameter data in livestock

AbstractGait assessments are a key part of determining the wellbeing of livestock. Techniques for gait assessment have traditionally involved human-eye inspections or reflective markers, but markerless computer vision methods have been developed in recent years. Despite many computer vision tools providing high-quality pose estimations in an efficient manner, they lack post-processing functionality. A review of model performance and calculation of gait parameters is a necessary step to fully harness the capability of this new technology. Thus, this study developed DeepLabCut-Display, an open-source desktop software application. DeepLabCut-Display allows a user to upload the video and coordinate data associated with the output of DeepLabCut, a prominent pose-estimation software tool. A user can review the video and coordinate data in parallel, filter points by a likelihood threshold, and automatically calculate gait parameters. Specific video frames, filtered data, and gait parameters can be exported from the application for further usage. The source code is publicly hosted on GitHub alongside installation and usage instructions. DeepLabCut-Display, the product of interdisciplinary and collaborative design between software developers and animal scientists, will alleviate a critical bottleneck in processing of data for locomotor analysis in livestock. Summary StatementO_LIDeepLabCut-Display is a utility to dynamically visualize raw marker coordinates, and to automatically produce gait parameters for locomotion analysis of horses and other livestock. C_LI Lay SummaryArtificial intelligence systems that can predict and track the positions of objects are now being applied in many fields, including animal science. Veterinarians and animal scientists use these systems to create pose estimations, a digital label of anatomical landmarks overlaid on a video of an animal in motion. They are used to quantify the subjects motion and detect anomalies that may be indicative of disease or injury. Pose estimation systems are efficient and accurate, but they lack features like data visualization and post-processing analysis that are necessary to make determinations about the animals motion. This study developed DeepLabCut-Display, a software application that can visualize the data from a pose estimation system and provides a set of tools for further analysis. After a user is done with analysis, they can save the results to their computer. The application was made by a collaboration between software developers and animal scientists, highlighting how interdisciplinary teams are effective at producing useful software.

animal behavior and cognition↗

bioRxiv2022

Evolution, Expansion and Characterization of Cannabinoid Synthase Gene Family in Cannabis Sativa

We are working toward a complete functional and genomic characterization of the cannabinoid synthase family in Cannabis (itself part of the larger Berberine Bridge Enzyme family). This clade, which is unique to Cannabis, includes four main subclades that appear to have arisen by a series of gene duplications. We have functionally characterized three cannabinoid synthases, in addition to the three already characterized, so that now all four subclades contain at least one characterized enzyme. The previously uncharacterized Clade C enzymes have relatively low activity and produce CBCA as their primary product. In addition, we report genomic characterization to better understand the structure and high level of copy number variation in this family. We report a pattern of shared regions immediately upstream of the cannabinoid synthase genes that suggests a specific sequence of breakpoints, and hence gene duplication events. We present a model of gene family expansion to account for the observed data, along with evidence that this expansion occurred under selective pressure. This work adds to our understanding of both the high level of variability in this family and the origin of THCA in type III plants lacking a functional THCAS gene.

genomics↗

bioRxiv2022

CADD from Chlamydia trachomatis is a manganese-dependent oxygenase that employs a self-sacrificing mechanism for the synthesis of p-aminobenzoate

CADD (chlamydia protein associating with death domains) is a p-aminobenzoate synthase involved in a non-canonical route for tetrahydrofolate biosynthesis in the intracellular bacterial pathogen, Chlamydia trachomatis. The previously solved crystal structure revealed a seven-helix bundle architecture similar to heme oxygenase with a diiron active site, making CADD a founding member of the emerging HDO (heme-oxygenase-like diiron oxidase) superfamily. The CADD-dependent route for pAB biosynthesis was shown to use L-tyrosine as a precursor, however, in vitro reactions were not stimulated by the addition of free L-tyrosine or other tyrosine-derived metabolites, leading to the proposal that the enzyme uses an internal active site tyrosine residue as a precursor to pAB. Here, we perform further biochemical characterization of CADD to clarify the details of the unique self-sacrificing reaction. Surprisingly, the pAB synthase reaction was shown to be dependent on manganese as opposed to iron and the data are most consistent with an active dimanganese cofactor analogous to class Ib and class Id ribonucleotide reductases. Experiments with 18O2 demonstrated the incorporation of two oxygen atoms from molecular oxygen into the pAB product, supporting the proposed mechanism requiring two monooxygenase reactions. Mass spectrometry-based proteomic analyses of CADD-derived peptides demonstrated a glycine substitution at Tyr27, a modification that was increased in reactions that produced pAB in vitro. Additionally, Lys152 was found to be deaminated and oxidized to aminoadipic acid. Taken together, our results support the conclusion that CADD is a manganese-dependent oxygenase that uses Tyr27 and possibly Lys152 as sacrificial substrates for pAB biosynthesis.

biochemistry↗

bioRxiv2021

Intra-Articular Delivery of an Indoleamine 2,3-Dioxygenase Galectin-3 Fusion Protein for Osteoarthritis Treatment in Male Lewis Rats

ObjectiveControlling joint inflammation can improve osteoarthritis (OA) symptoms; however, current treatments often fail to provide long-term effects. We have developed an indoleamine 2,3-dioxygenase and galectin-3 fusion protein (IDO-Gal3). IDO converts tryptophan to kynurenines, directing the local environment toward an anti-inflammatory state; Gal3 binds carbohydrates and extends IDOs joint residence time. In this study, we evaluated IDO-Gal3s ability to alter OA-associated inflammation and pain-related behaviors in a rat model of established knee OA. MethodsJoint residence was first evaluated with an analog Gal3 fusion protein (NanoLuc and Gal3, NL-Gal3) that produces luminescence from furimazine. OA was induced in male Lewis rats via a medial collateral ligament and medial meniscus transection (MCLT+MMT). At 8 weeks, NL or NL-Gal3 were injected intra-articularly (n=8 per group), and bioluminescence was tracked for 4 weeks. Next, IDO-Gal3s ability to modulate OA pain and inflammation was assessed. Again, OA was induced via MCLT+MMT in male Lewis rats, with IDO-Gal3 or saline injected into OA-affected knees at 8 weeks post-surgery (n=7 per group). Gait and tactile sensitivity were then assessed weekly. At 12 weeks, intra-articular levels of IL6, CCL2, and CTXII were assessed. ResultsThe Gal3 fusion increased joint residence in OA and contralateral knees (p<0.0001). In OA-affected animals, IDO-Gal3 improved tactile sensitivity (p=0.002), increased walking velocities (p[≤]0.033), and improved vertical ground reaction forces (p[≤]0.04). Finally, IDO-Gal3 decreased intra-articular IL6 levels within the OA-affected joint (p=0.0025). ConclusionIntra-articular IDO-Gal3 delivery provided long-term modulation of joint inflammation and pain-related behaviors in rats with established OA.

bioengineering↗

bioRxiv2021

Galectin-anchored indoleamine 2,3-dioxygenase suppresses local inflammation

Summary paragraphChronic inflammation underlies the onset, progression and associated pain of numerous diseases.(1) Current anti-inflammatory treatments administered systemically are associated with moderate-to-severe side effects, while locally administered drugs have short-lived efficacy, and neither approach successfully modifies the underlying causality of disease.(2) We report a new way to locally modulate inflammation by fusing the enzyme indoleamine 2,3-dioxygenase 1 (IDO) to galectin-3 (Gal3). A general regulator of inflammation(3), IDO is immunosuppressive(4), catabolizing the essential amino acid tryptophan into kynurenine.(5) Recently we demonstrated that extracellular exogenous IDO regulates innate immune cell function(6), and envisioned delivering IDO into specific tissues would provide control of inflammation. However, proteins problematically diffuse away from local injection sites. Addressing this, we recently established that fusion to Gal3 anchors enzymes to tissues(7) via binding to extracellular glycans. Fusion protein IDO-Gal3 was retained in injected tissues and joints for up to a week or more, where it suppressed local inflammation in rodent models of endotoxin-induced inflammation, psoriasis, periodontal disease and osteoarthritis. Amelioration of local inflammation, disease progression and inflammatory pain were concomitant with homeostatic preservation of tissues without global immune suppression. Thus, IDO-Gal3 presents a new concept of anchoring immunomodulatory enzymes for robust control of focal inflammation in multiple disease settings.

bioengineering↗